We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Supreme Court Lets Merck Loss In Fosamax Case Stand

Law360 (October 17, 2005, 12:00 AM EDT) -- In a setback for Merck & Co., the U.S. Supreme Court has rejected the company’s appeal of a decision that shaved a decade off the patent for blockbuster osteoporosis drug Fosamax....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.